Evolution of DNA methylation is linked to genetic aberrations in 2 chronic lymphocytic leukemia
نویسندگان
چکیده
4 5 Christopher C. Oakes, Rainer Claus, Lei Gu, Yassen Assenov, Jennifer Hüllein, 6 Manuela Zucknick, Matthias Bieg, David Brocks, Olga Bogatyrova, Christopher R. 7 Schmidt, Laura Rassenti, Thomas J. Kipps, Daniel Mertens, Peter Lichter, 8 Hartmut Döhner, Stephan Stilgenbauer, John C. Byrd, Thorsten Zenz and 9 Christoph Plass 10 11 12 Affiliations: Division of Epigenomics and Cancer Risk Factors, Theoretical 13 Bioinformatics, Biostatistics and Molecular Genetics, The German Cancer Research 14 Center (DKFZ), Heidelberg, Germany; Department of Medicine, University of Freiburg 15 Medical Center, Freiburg, Germany; Department of Translational Oncology, National 16 Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), 17 Heidelberg, Germany; Department of Medicine V, University of Heidelberg, Heidelberg, 18 Germany; Department of Medicine, University of California at San Diego Moores 19 Cancer Center, La Jolla, USA; Department of Internal Medicine III, University of Ulm, 20 Ulm, Germany; Division of Hematology, The Ohio State University, Columbus, USA; 21 The German Cancer Consortium. 22
منابع مشابه
Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemia.
Although clonal selection by genetic driver aberrations in cancer is well documented, the ability of epigenetic alterations to promote tumor evolution is undefined. We used 450k arrays and next-generation sequencing to evaluate intratumor heterogeneity and evolution of DNA methylation and genetic aberrations in chronic lymphocytic leukemia (CLL). CLL cases exhibit vast interpatient differences ...
متن کاملp53 Aberrations do not predict individual response to fludarabine in patients with B-cell chronic lymphocytic leukaemia in advanced stages Rai III/IV.
Abnormalities of p53 have been associated with short survival and non-response to therapy in chronic lymphocytic leukaemia (CLL). We have evaluated the rate of response to fludarabine as first-line therapy in 54 patients with advanced stage CLL, analysing the cytogenetic profile, aberrations in p53, including the methylation status of its promoter, and the immunoglobulin heavy-chain variable-re...
متن کاملLocally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia.
Intratumoral heterogeneity plays a critical role in tumor evolution. To define the contribution of DNA methylation to heterogeneity within tumors, we performed genome-scale bisulfite sequencing of 104 primary chronic lymphocytic leukemias (CLLs). Compared with 26 normal B cell samples, CLLs consistently displayed higher intrasample variability of DNA methylation patterns across the genome, whic...
متن کاملCD38 gene polymorphisms and genetic susceptibility to chronic lymphocytic leukemia
Introduction: CLL is one of the most common leukemias, which is categorized by the accumulation of mature CD5+ B-lymphocytes in the peripheral blood, bone marrow, and secondary lymphoid organs. In this study, the status of rs6449182 polymorphism of the CD38 gene and its association with clinical and laboratory parameters of CLL patients was evaluated. Methods: Genomic DNA extraction was perfor...
متن کاملAn Unusual Case Report: Occurrence of Renal Cell Carcinoma, Basal Cell Carcinoma and Chronic Lymphocytic Leukemia in a Case of Papillary Thyroid Carcinoma Treated with Radioactive Iodine
The standard therapy for thyroid cancer is total or near total thyroidectomy, followed by the administration of radioactive iodine for remnant ablation or residual disease. Patients with radioiodine therapy are predisposed to second malignant neoplasms in organs such as central nervous system (CNS), breast, prostate, kidney, bone marrow, salivary gland, and digestive tract. Exposure to carcinog...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2013